Lean clinical delivery for emerging and mid-sized biotechs. We assemble expert, fractional study teams and lead a consortium of specialist partners. You keep sponsor control, we remove rework, delay and hidden cost.
Eblex Clinical assembles expert, fractional study teams and leads a consortium of carefully selected specialist partners. You pay only for the service you actually need, when you need it, no bundled PMO layers, no duplicated oversight, clear RACI from day one.
Clinical Project Management, CRAs, CTAs, Regulatory, GCP, Medical, Biostatistics, TMF and Data Operations, deployed on a fractional, scalable basis and flexed up or down without renegotiating a full CRO contract.
Senior-level clinical oversight across study design and delivery, so decisions are made once, correctly, and carried through the study without rework. Sponsors without in-house clinical leadership can execute with confidence.
Sponsors pay for the expertise they actually use, when they use it, with no bundled overhead.
Continuous audit readiness through compliant TMF and QMS frameworks, no late-stage reconstruction, reduced inspection risk, nothing to build on the sponsor side.
Real-time visibility into progress, documents and decisions, with full sponsor oversight retained throughout, not retrospective status reports.
Eblex Clinical leads a consortium of carefully selected partners, so a single point of accountability gives you everything a study needs, without stitching together vendors.
The functional study team, Project Management, CRAs, CTAs, Regulatory, GCP, Medical, Biostatistics, TMF and Data Operations, deployed fractionally and scaled to your study.
Senior-level oversight and operational leadership across study design and delivery, reducing false starts and downstream amendments, so decisions are made once and carried through.
An ISO 27001-certified, GxP-ready platform used as the standard operating system across Eblex studies, automating documents and QA with immutable audit trails and live oversight dashboards.
You retain sponsor control while we coordinate the consortium, removing rework, delay and hidden overhead from clinical delivery.
Plan your study →Our model is built for early-phase studies where speed, cost control and oversight matter most. Where a full-service CRO is the better answer, we tell you.
Sponsors see where time and money go, in real time. You keep full oversight and decision-making authority, and scale support up or down as the study evolves.
Eblex Clinical provides the functional study team across operations, data, quality and regulatory, deployed fractionally and scaled to your study.
With no in-house clinical function and limited compliance capability, the company turned to Eblex Clinical. We assembled a fractional project team to run the study while they stayed focused on product development and growth. Each consultant engaged on a fractional basis, averaging 0.6 FTE across the team.
We deliver the exact services needed to manage and execute your studies, giving you direct access to senior decision-makers from first call to close-out.
Simplifies complex trial delivery by building and executing robust service strategies, keeping your infrastructure aligned with business goals to hit clinical milestones faster.
Keeping teams aligned and removing internal friction making sure every study runs on Cori with clean data, compliant documents and live oversight from day one.
Eblex Clinical delivers CRO-grade clinical trial support without full CRO overhead. We assemble expert, fractional study teams and lead a consortium of specialist partners for emerging and mid-sized biotechs, while sponsors keep full control.
We use fractional expert teams instead of fixed work packages, with transparent FTE-plus-platform pricing, live dashboards, auto-generated and checked documentation, and continuous audit-readiness, so sponsors see where time and money go, in real time.
First-in-human and early-phase studies, single-country or regional trials, and single or multi-site studies of 1 to 12 sites, for emerging and mid-sized sponsors who want to retain oversight. For large, fully-outsourced late-phase programmes, we will tell you when a full CRO is the better fit.
Yes. You retain full sponsor oversight and decision-making authority, with real-time visibility into progress, documents and decisions, and the flexibility to scale support up or down as the study evolves.
If you're preparing for an early-phase programme and want structural clarity on delivery, cost and oversight, we're available for a focused discussion. A short conversation is often enough to know whether this model fits.